Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Stem Cells May Be at Root of Cancer

New Research May Explain Why So Many Tumor-Fighting Treatments Now Fail

A New Model for Cancer continued...

If the treatments targeted the cancer stem cells, however, the tumor would lose the ability to generate new cancer cells, eventually resulting in a cure, Wicha says.

Think dandelions, says researcher Peter Chu, PhD, of Biogen Idec in San Diego. "If you cut a weed and don't get the root, it will grow back," he tells WebMD. "So if you don't [kill off] cancer stem cells, you're not going to see better long-term survival."

Wicha notes that the concept that stem cells cause cancer is not new. But recent advances in molecular biology -- such as the development of tests that allow researchers to locate and measure the cancer stem cells -- are giving it new credibility, he says.

Stem Cells Drive Aggressive Breast Tumors

Experiments in Wicha's lab show that two genes, PTEN and HER2/neu, that are associated with aggressive breast cancers have stem cell properties. Defects in either gene are tied to faster-growing tumors that are more likely to return.

The researchers studied three types of genetically altered breast cancer cells: One had the PTEN defect, one had the HER2/neu defect, and one had both genetic alterations.

Results showed that that either defect increases the stem cell population by two to five times. Furthermore, there was an approximately tenfold increase in the stem cell population when they created a cell line with both PTEN and HER2/neu defects.

Then, the researchers injected the three types of genetically altered cells into mice. Cells with either defect induced the growth of tumors that were four to six times more aggressive than normal. Injection of the cells with both alterations caused tumors that were 10 times more aggressive.

Wicha believes the experiments may help explain why Herceptin, the biologic therapy that targets the HER2 protein on cancer cells, works so well.

"We believe that knocking out the tumor-causing cancer stem cells explains why Herceptin reduces that chance of cancer coming back by 50% [in women with HER2 positive breast cancer], although that remains to be proven," he says.

Today on WebMD

Building a Support System
cancer fighting foods
precancerous lesions slideshow
quit smoking tips
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas